T Lymphoblastic Lymphoma — Trials

T Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04582487	Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL	unknown	N/A	32	Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER	1	Feb 7, 2024	clinicaltrials
NCT04620655	RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL	unknown	N/A	24	Min XiangOTHER	1	Nov 9, 2020	clinicaltrials